RSB Spine, LLC, was formed in 2001 as R&B Surgical Solutions by John A. Redmond and Robert S. Bray, JR, M.D. to develop and market spinal implant concepts from Dr. Bray and other innovative spine surgeons. The Company, headquartered in Cleveland, OH, initially developed a line of surgical instruments similar to Redmond’s previous company, Redmond Neurotechnologies Corp, which was acquired by Neurocare in 1997. In August 2006 RSB Spine received FDA approval for its newest product, the InterPlate™, as a vertebral body replacement. The InterPlate is a platform technology for performing fusions in the lumbar and cervical spine. The implants, made from both titanium and PEEK, offer surgeons a very unique and different option as compared with plates and interbody devices. In July 2007 FDA reclassified interbody fusion devices and as of September 18, 2007 the InterPlate became the first device cleared for interbody fusion under the new guidelines.
The current InterPlate, sold for use in the cervical and lumbar spine, is made of titanium and is used in conjunction with graft material for fusion of the two vertebral bodies. RSB Spine’s products are exclusively distributed by Paradigm BioDevices in the United States. http://www.rsbspine.com
About the Spinal Market
The Spinal implants and spinal devices market, by technology, includes spinal fusion and fixation, vertebral compression fracture treatment, and motion preservation/non-fusion technologies. On the basis of products, the global spinal implants and spinal devices market is divided into six major segments, namely, thoracic fusion and lumbar fusion devices, cervical fusion devices, spine biologics, vertebral compression fracture treatment devices, motion preservation/non-fusion treatment devices, and spine bone stimulators. Bases on the type of surgery, the global spinal implants and spinal devices market is divided into two segments, namely, open surgery and minimally invasive surgery. The spinal decompression devices market, by type of procedure, covers discectomy, laminotomy/laminectomy, foraminotomy/foraminectomy, facetectomy, and corpectomy procedures.
The Spinal market is expected to reach USD 15.73 Billion by 2020, growing at a CAGR of 5.6% from 2015 to 2020. As of 2015, North America is estimated to hold the largest share of the global spinal implants and spinal devices market, followed by Europe. However, the Asia-Pacific market is expected to grow at the highest CAGR of 8.2% from 2015 to 2020. A number of factors, including rising healthcare expenditure in developing nations owing to growing income levels, increasing government funding, presence of a large patient population, rising obesity cases, and growing awareness on the newly developed spine treatment techniques and devices are propelling the growth of the spinal implants and spinal devices market in the Asia-Pacific region. However, challenges associated with this market, such as scarcity of expertise and trained healthcare workers and lack of adequate patient awareness restricts the market growth in this region.
Source: marketsandmarkets.com